Fundraising Fox

MIVI Neuroscience

Eden Prairie, US · Founded 2014 · Delaware corporation

MIVI develops medical devices to improve outcomes in neurointerventional procedures, specifically targeting aspiration in distal stroke occlusions and reducing distal embolization during mechanical thrombectomy.

Deep TechHealthtechMedical Devices

Founders & leadership

MO
Matthew OglePresident & CEO

Board

GF
George FazioBoard director
BC
Benjamin ConstableBoard director
JO
John O'MearaBoard director

Reported raises · per SEC filings

Form D private placements

$67.4M disclosed across 9 rounds · 2017–2024

▶$510KraisedMay 2024 · 9 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Craig YeshionDirector
  • Nathan HarringtonDirector
  • Tim HauchExecutive Officer
  • Robert SternDirector
  • Chris DeweyDirector
  • Robert CollotonExecutive Officer, Director
  • Taylor WhitmanDirector
Offering amount
$9.3M
Amount sold
$510K
Sales commissions
$250K
Placement agents
Ceros Financial Services, Inc.
First sale
May 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$9.6MraisedAug 2023 · 83 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Craig YeshionDirector
  • Nathan HarringtonDirector
  • Tim HauchExecutive Officer
  • Taylor WhitmanDirector
  • Chris DeweyDirector
  • Robert CollotonExecutive Officer, Director
  • Robert SternDirector
Offering amount
$10M
Amount sold
$9.6M
First sale
Jul 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$45MraisedDec 2020 · 48 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Robert CollotonExecutive Officer, Director
  • Sean ChengDirector
  • Craig YeshtonDirector
  • Robert SternDirector
  • Taylor WhitmanDirector
  • Frederic MollDirector
Offering amount
$45M
Amount sold
$45M
First sale
Dec 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2.2MraisedMar 2020 · 44 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • James McCollumExecutive Officer, Director
  • Benjamin ConstableDirector
  • Christopher DeweyDirector
  • Maurice FerreDirector
  • Taylor WhitmanDirector
  • Frederic MollDirector
  • Matthew OgleExecutive Officer
Offering amount
$2.5M
Amount sold
$2.2M
First sale
Mar 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$3.2MraisedFeb 2019 · 17 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Fred MollDirector
  • James McCollumExecutive Officer, Director
  • John O'MearaDirector
  • Matthew OgleExecutive Officer, Director
  • Benjamin ConstableDirector
Offering amount
$10M
Amount sold
$3.2M
First sale
Jan 2019
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$500KraisedDec 2018 · 4 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Fred MollDirector
  • Matthew OgleExecutive Officer, Director
  • John O'MearaDirector
  • James McCollumExecutive Officer, Director
  • Benjamin ConstableDirector
Offering amount
$1M
Amount sold
$500K
First sale
Nov 2018
Incorporated
Corporation, Delaware, 2014
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.6MraisedSep 2017 · 27 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Christopher GeyenExecutive Officer
  • George FazioDirector
  • Benjamin ConstableDirector
  • Matthew OgleExecutive Officer, Director
  • John O'MearaDirector
Offering amount
$1.6M
Amount sold
$1.6M
First sale
Sep 2017
Incorporated
Corporation, Delaware, 2014
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$4MraisedAug 2017 · 1 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Matthew OgleExecutive Officer, Director
  • John O'MearaDirector
  • George FazioDirector
  • Benjamin ConstableDirector
  • Christopher GeyenExecutive Officer
Offering amount
$4M
Amount sold
$4M
First sale
Aug 2017
Incorporated
Corporation, Delaware, 2014
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 1

by search overlap
MICROVI BIOTECH, INC.3 shared keywordsMicrovi is a biotechnology company that develops MicroNiche Engineering (MNE) biocatalyst systems for water and wastewater treatment, including nitrogen, nitrate, phosphorus, and hexavalent chromium removal, as well as industrial bioprocessing applications. It serves municipal water utilities and industrial customers across the United States and United Kingdom.

Companies competing with MIVI Neuroscience for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does MIVI Neuroscience do?
MIVI develops medical devices to improve outcomes in neurointerventional procedures, specifically targeting aspiration in distal stroke occlusions and reducing distal embolization during mechanical thrombectomy.
How much funding has MIVI Neuroscience raised?
MIVI Neuroscience has disclosed $67.4M raised across 9 rounds.
Where is MIVI Neuroscience headquartered?
MIVI Neuroscience is headquartered in Eden Prairie, US.